(Q36309974)

13 August 2017

Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study (English)

1 reference

13 August 2017

hepatocellular carcinoma

1 reference

Giuseppe Cabibbo

1

1 reference

13 August 2017

Giuseppe Cabibbo

2

1 reference

13 August 2017

Marcello Maida

3

1 reference

13 August 2017

Chiara Genco

4

1 reference

13 August 2017

Pietro Parisi

5

1 reference

13 August 2017

Marco Peralta

6

1 reference

13 August 2017

Michela Antonucci

7

1 reference

13 August 2017

Giuseppe Brancatelli

8

1 reference

13 August 2017

Calogero Cammà

9

1 reference

13 August 2017

Antonio Craxì

10

1 reference

13 August 2017

Vito Di Marco

11

1 reference

13 August 2017

1 September 2012

1 reference

World Journal of Hepatology

13 August 2017

1 reference

13 August 2017

4

1 reference

13 August 2017

9

1 reference

13 August 2017

256-261

1 reference

Second-line therapies in hepatocellular carcinoma: emergence of resistance to sorafenib

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Should cirrhosis change our attitude towards treating non-hepatic cancer?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenib

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

30 September 2017

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Targeted therapies for hepatocellular carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Management of hepatocellular carcinoma: An update

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

New strategies in hepatocellular carcinoma: genomic prognostic markers.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Multimodal approaches to the treatment of hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Sorafenib in advanced hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Design and endpoints of clinical trials in hepatocellular carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Genomics and signaling pathways in hepatocellular carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Management of hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Prognosis of hepatocellular carcinoma: the BCLC staging classification

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Toxicity and response criteria of the Eastern Cooperative Oncology Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468702

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

22 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.4254%2FWJH.V4.I9.256

Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: A prospective study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.4254%2FWJH.V4.I9.256

Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.4254%2FWJH.V4.I9.256

Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems

21 January 2018

1 reference

12 December 2020

Minor hepatic resection using heat coagulative necrosis

1 reference

12 December 2020

Sorafenib therapy in patients with advanced hepatocellular carcinoma in advanced liver cirrhosis

1 reference

12 December 2020

Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation

1 reference

12 December 2020

Identifiers

DOI

10.4254/WJH.V4.I9.256

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

23060970

1 reference